BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29724029)

  • 1. Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation.
    Cabrera D; Cabello-Verrugio C; Solís N; San Martín D; Cofré C; Pizarro M; Arab JP; Abrigo J; Campos F; Irigoyen B; Carrasco-Avino G; Bezares K; Riquelme V; Riquelme A; Arrese M; Barrera F
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29724029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.
    Cabrera D; Ruiz A; Cabello-Verrugio C; Brandan E; Estrada L; Pizarro M; Solis N; Torres J; Barrera F; Arrese M
    Dig Dis Sci; 2016 Nov; 61(11):3190-3198. PubMed ID: 27572941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
    J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
    Duan X; Meng Q; Wang C; Liu Z; Sun H; Huo X; Sun P; Ma X; Peng J; Liu K
    J Gastroenterol Hepatol; 2018 Feb; 33(2):533-542. PubMed ID: 28699662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats.
    Akaslan SB; Degertekin CK; Yilmaz G; Cakir N; Arslan M; Toruner FB
    Metab Syndr Relat Disord; 2013 Aug; 11(4):243-50. PubMed ID: 23544853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin mediates the additive effects of combining daily exercise with caloric restriction for treatment of non-alcoholic fatty liver.
    Cho J; Koh Y; Han J; Kim D; Kim T; Kang H
    Int J Obes (Lond); 2016 Nov; 40(11):1760-1767. PubMed ID: 27216820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis.
    Hirotani Y; Ozaki N; Tsuji Y; Urashima Y; Myotoku M
    Int J Food Sci Nutr; 2015; 66(5):569-73. PubMed ID: 26017323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAR2 deficiency ameliorates non-alcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1.
    Kung ML; Yang TH; Lin CC; Ho JY; Hung TC; Chang CH; Huang KW; Chen CC; Chen YW
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):949-962. PubMed ID: 38533529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Chinese Medicinal Formula BNG-1 on Phosphodiesterase 3B Expression, Hepatic Steatosis, and Insulin Resistance in High Fat Diet-induced NAFLD Mice.
    Guo CH; Chen WL; Liao CH; Huang K; Chen PY; Yang CP
    Int J Med Sci; 2018; 15(11):1194-1202. PubMed ID: 30123057
    [No Abstract]   [Full Text] [Related]  

  • 12. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
    Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.
    Rodriguez-Echevarria R; Macias-Barragan J; Parra-Vargas M; Davila-Rodriguez JR; Amezcua-Galvez E; Armendariz-Borunda J
    World J Gastroenterol; 2018 Jan; 24(4):461-474. PubMed ID: 29398867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet.
    Lee MR; Park KI; Ma JY
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29295591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
    Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
    Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice.
    Choi S; Choi Y; Choi Y; Kim S; Jang J; Park T
    Food Chem; 2013 Dec; 141(4):3627-35. PubMed ID: 23993530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of dietary carbohydrates induces hepatic growth hormone (GH) resistance in rats.
    Bielohuby M; Sawitzky M; Stoehr BJ; Stock P; Menhofer D; Ebensing S; Bjerre M; Frystyk J; Binder G; Strasburger C; Wu Z; Christ B; Hoeflich A; Bidlingmaier M
    Endocrinology; 2011 May; 152(5):1948-60. PubMed ID: 21427215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a low-fat diet on the hepatic expression of adiponectin and its receptors in rats with NAFLD.
    Ma H; You GP; Cui F; Chen LF; Yang XJ; Chen LG; Lu HD; Zhang WQ
    Ann Hepatol; 2015; 14(1):108-17. PubMed ID: 25536648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice.
    Hong SA; Jung IR; Choi SE; Hwang Y; Lee SJ; Son Y; Heo YJ; Cui R; Han SJ; Kim HJ; Lee KW; Kang Y
    Sci Rep; 2019 Nov; 9(1):17839. PubMed ID: 31780766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.